NGM Biopharmaceuticals, Inc. Return on Tangible Equity 2018-2023 | NGM

Current and historical return on tangible equity values for NGM Biopharmaceuticals, Inc. (NGM) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
Return On Tangible Equity Historical Data
Date TTM Net Income Tangible Equity Return on Tangible Equity
2023-12-31 $-0.14B $0.15B -78.14%
2023-09-30 $-0.15B $0.17B -71.65%
2023-06-30 $-0.17B $0.19B -70.49%
2023-03-31 $-0.18B $0.22B -67.23%
2022-12-31 $-0.16B $0.26B -56.40%
2022-09-30 $-0.15B $0.29B -49.96%
2022-06-30 $-0.14B $0.29B -41.76%
2022-03-31 $-0.13B $0.31B -36.39%
2021-12-31 $-0.12B $0.34B -33.08%
2021-09-30 $-0.12B $0.35B -34.68%
2021-06-30 $-0.12B $0.37B -36.99%
2021-03-31 $-0.11B $0.40B -35.61%
2020-12-31 $-0.10B $0.28B -35.00%
2020-09-30 $-0.09B $0.28B -29.64%
2020-06-30 $-0.07B $0.30B -22.33%
2020-03-31 $-0.05B $0.32B -16.18%
2019-12-31 $-0.04B $0.33B -19.18%
2019-09-30 $-0.01B $0.34B -11.35%
2019-06-30 $-0.01B $0.35B -33.61%
2019-03-31 $-0.01B $-0.12B 8.81%
2018-12-31 $-0.00B $-0.11B 3.70%